Related Experiment Videos
Drug therapy for obesity: an update
1Department of Pharmacy Practice, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Ind, USA.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|January 1, 1997
Summary
Calorie-restricted diets are ineffective for weight loss. Drug therapy, particularly serotonergic drugs, shows short-term efficacy for weight loss, but unapproved nonprescription drugs carry risks.
Area of Science:
- Pharmacology
- Obesity Medicine
- Weight Management
Background:
- Calorie-restricted diets are often ineffective for sustainable weight loss.
- Obesity drug therapy is indicated for patients with comorbidities or at risk.
- Amphetamine derivatives are explored for appetite suppression with reduced abuse potential.
Purpose of the Study:
- To evaluate the efficacy and risks of various weight loss strategies.
- To identify suitable candidates for obesity pharmacotherapy.
- To assess the safety and effectiveness of approved and non-approved weight loss drugs.
Main Methods:
- Review of existing studies on diet, pharmacotherapy, and weight loss.
- Analysis of the central nervous system effects of amphetamines.
- Examination of serotonergic drug effects on weight.
- Assessment of risks associated with nonprescription weight loss products.
Main Results:
- Calorie restriction is often counterproductive for weight loss.
- Serotonergic drugs demonstrate short-term weight loss induction.
- Drug therapy is best suited for patients with obesity-related comorbidities.
- Nonprescription weight loss drugs lack proven efficacy and may pose serious risks.
Conclusions:
- Pharmacotherapy, particularly with serotonergic agents, offers a potential avenue for weight loss.
- Careful patient selection is crucial for effective obesity drug therapy.
- Patients must be cautioned about the unproven efficacy and potential dangers of nonprescription weight loss aids.